These cheap shares may be takeover targets in 2025, and as such, potentially offer shareholders the chance to earn outsized returns.

Gland Pharma announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Pashamylaram facility at Hyderabad.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

President Biden shocked the financial markets, his own national-security leadership and America’s alliance partners with a ...

Dell Technologies Inc. (NYSE:DELL), with a market capitalization of $76.72 billion, finds itself at a pivotal juncture as it ...

In fact, AMD has been underperforming the broader semiconductor industry over the past five years. This is evident from the 141% gains clocked by AMD during this period as compared to the 170% jump in ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Stocks closed out the week with a bang as Treasury yields retreated from recent highs. Optimism is swirling ahead of ...

Despite the stellar stock market gains of 2024, an era of American exceptionalism seems to be only just beginning, which ...

Tesla's stock (TSLA) powered up 6% in afternoon trading, to provide an $80.2 billion boost to the company's market capitalization, which is currently at $1.41 trillion. Since Trump's election win, the ...

Crypto company Digital Currency Group agreed to pay a $38 million fine to settle with the Securities and Exchange Commission ...

Bitcoin's bull market failed to spur a major uptick in crypto venture capital in 2024, signaling caution among institutional ...